SCHEMBL9786663

SCHEMBL9786663

CNC(=S)c1[nH]c(=S)[nH]c1C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9786606 0.77 BRD4 (0.47) KDM4ERXFP1
SCHEMBL9786655 0.77 GAA (0.41) KDM4E
SCHEMBL7037055 0.66 — —
SCHEMBL9629049 0.52 GAA (0.46) —
SCHEMBL36504 0.52 — —
SCHEMBL1694963 0.46 — —
SCHEMBL3070619 0.46 — —
SCHEMBL47369 0.46 — —
SCHEMBL45851 0.46 — —
Water SCHEMBL29512200 0.46 ALDH1A1 (0.39) KDM4ERXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5002961-A Antiischemic Agents, Preventing Reperfusion Injuries MERRELL DOW PHARMACEUTICALS (US) 1991-03-26 — — US disclosed
EP-0312960-A2 Method for reducing reperfusion injury with imidazol-2-thione-carboxamides MERRELL DOW PHARMACEUTICALS INC. (US) 1989-04-26 — — EP disclosed
Send feedback